This content is machine translated Rare diseases Fanconi-Bickel syndrome Fanconi-Bickel syndrome (FBS) occurs due to variants in the SLC2A2 gene. The diagnosis of a rare genetic disease can take up to 5-6 years, even longer in low and middle…
View Post 11 min This content is machine translated Malignancies Therapy of esophageal carcinoma – an overview Esophageal carcinomas are comparatively rare tumors and account for approximately 1% of all malignancies worldwide. Based on their location, a distinction is made between cervical and intrathoracic tumors. Histologically, they… CME-Test
View Post 4 min This content is machine translated From symptom to diagnosis Abdominal pain – intussusception and other displacements of the bowel In intussusception, a section of bowel is pushed into the neighboring section. This change is also known as intussusception. The intussuscepted part of the intestine is the invaginate, the receiving…
View Post 3 min This content is machine translated Journal Club CED-associated intestinal microbes identified Millions of people worldwide suffer from inflammatory bowel disease (IBD) and the prevalence is increasing. To find out more about the role of the microbiome, researchers at Massachusetts General Hospital…
View Post 4 min This content is machine translated From symptom to diagnosis Abdominal pain – Steatosis hepatis In steatotic liver diseases, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are distinguished from alcoholic fatty liver disease (AFLD) and alcoholic steatohepatitis (ASH) from an etiological point of…
View Post 7 min This content is machine translated Chronic inflammatory bowel disease The combination for a better outcome Current therapeutic strategies for inflammatory bowel disease (IBD) have reached a plateau in terms of response and/or remission rates achieved with a single therapeutic agent. Consequently, advanced combination therapy (ACT)…
View Post 5 min This content is machine translated Sponsored Content: UEGW update: Post-hoc analyses of the SEQUENCE study Risankizumab is convincing compared to ustekinumab [1] The SEQUENCE comparative study recently published in the New England Journal of Medicine (NEJM) compared the two interleukin (IL)-23 and IL-12/-23 inhibitors risankizumab (SKYRIZI®) and ustekinumab in Crohn’s disease (CD)…
View Post 11 min This content is machine translated IBD matters - clinical studies Differences in design and their significance for interpretation What study phases does a new active substance go through before it reaches clinical practice? What differences are there in the designs of clinical trials?Which aspects are important for interpreting… CME-Test
View Post 18 min This content is machine translated Irritable Bowel Syndrome Guideline-based therapy of IBS according to the biopsychosocial model The biopsychosocial model considers various somatic and psychosocial factors within the pathophysiology of IBS and integrates their multifaceted interaction processes. In addition, therapeutic starting points can be identified and implemented… CME-Test
View Post 1 min This content is machine translated Sponsored Content: Interdisciplinary training event New Horizons: Knowledge to the power of three (6. February 2025) Practical knowledge networking, recognizing connections, understanding immune-mediated chronic inflammatory diseases and interdisciplinary treatment. Take part in New Horizons: knowledge to the power of three.
